Immune-Modulating Dual-Targeted Nanomaterials for Low-Temperature Photothermal–Photodynamic–Chemodynamic Therapy of Osteosarcoma Targeting Tumor and Endothelial Cells
ACS Nano · 02.09.2025 · 19 (34) · 30786-30809
DOI: 10.1021/acsnano.5c00223 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Nano, online erschienen am 20.08.2025. Verfasst von Qing Pan und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopaedics, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China. Hauptthemen laut MEDLINE: Osteosarcoma, Photochemotherapy, Bone Neoplasms, Endothelial Cells. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key Research and Development Program of China, National Natural Science Foundation of China.
Abstract (Originalsprache)
Osteosarcoma is a highly aggressive bone tumor with limited treatment options because of its drug resistance and tumor heterogeneity. In this study, we developed a multifunctional nanomaterial, P-Fe3O4@Pal@HM, combining porous Fe3O4 nanoparticles, the DNA intercalator palmatine, and a hybrid membrane coating derived from osteosarcoma cells and tumor-associated endothelial cells. The Fe3O4 core facilitates a Fenton-like reaction, generating reactive oxygen species (ROS) to enhance DNA damage, whereas palmatine (Pal) inhibits RRM2 (ribonucleotide reductase regulatory subunit M2) expression, blocking DNA repair and inducing apoptosis. The hybrid membrane coating provides precise targeting of both tumor and endothelial cells, thus addressing the challenge of tumor heterogeneity. Under low-temperature photothermal conditions, the Fenton-like reaction is further enhanced, boosting ROS production and increasing cytotoxicity. This nanomaterial also modulates the immune microenvironment by promoting M1 macrophage polarization, thereby amplifying the antitumor immune response. P-Fe3O4@Pal@HM demonstrated superior therapeutic efficacy to conventional treatments, significantly reducing tumor volume and inducing apoptosis with minimal toxicity to normal tissues. This innovative approach offers a promising strategy to overcome drug resistance, improve tumor targeting, and enhance treatment outcomes in osteosarcoma. The multifunctional design of P-Fe3O4@Pal@HM highlights its potential as an advanced therapeutic platform in osteosarcoma.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Orthopaedics, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China.
- Department of Orthopaedics, Shanxi Medical University Second Affiliated Hospital, Taiyuan, Shanxi 030001, China.
- Department of Orthopaedics, Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai 200080, China.
ORCID-Profile: Yongzhi Cui, Zengwu Shao
Förderung
- National Key Research and Development Program of China
- National Natural Science Foundation of China
Zitieren
APA
Pan, Q., Wu, W., Jing, D., Huang, W., Cui, Y., Zhang, Z., Shao, Z., Hu, H., & Yang, W. (2025). Immune-Modulating Dual-Targeted Nanomaterials for Low-Temperature Photothermal–Photodynamic–Chemodynamic Therapy of Osteosarcoma Targeting Tumor and Endothelial Cells. ACS Nano, 19(34), 30786-30809. https://doi.org/10.1021/acsnano.5c00223
Vancouver
Pan Q, Wu W, Jing D, Huang W, Cui Y, Zhang Z, et al. Immune-Modulating Dual-Targeted Nanomaterials for Low-Temperature Photothermal–Photodynamic–Chemodynamic Therapy of Osteosarcoma Targeting Tumor and Endothelial Cells. ACS Nano. 2025;19(34):30786-30809. doi:10.1021/acsnano.5c00223
BibTeX
@article{Pan2025,
author = {Pan, Qing and Wu, Wei and Jing, Doudou and Huang, Wei and Cui, Yongzhi and Zhang, Zhicai and Shao, Zengwu and Hu, Hongzhi and Yang, Wenbo},
title = {Immune-Modulating Dual-Targeted Nanomaterials for Low-Temperature Photothermal–Photodynamic–Chemodynamic Therapy of Osteosarcoma Targeting Tumor and Endothelial Cells},
journal = {ACS Nano},
year = {2025},
volume = {19},
number = {34},
pages = {30786--30809},
doi = {10.1021/acsnano.5c00223}
}
EUVIMED